Iberdomide Combination Therapy (KID)

Carfilzomib, Iberdomide (CC-220) and Dexamethasone (KID) in Transplant Eligible Multiple Myeloma

Arms / Cohorts

Experimental Arm:Iberdomide (1.1 mg) + Carfilzomib + Dexamethasone

Not currently accepting

Experimental Arm:Iberdomide (1.3 mg) + Carfilzomib + Dexamethasone

Not currently accepting

Experimental Arm:Iberdomide (1.6 mg) + Carfilzomib + Dexamethasone

Not currently accepting

Experimental Arm:Iberdomide (0.75 mg) + Carfilzomib + Dexamethasone

Not currently accepting

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.